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The main goal of genetic disease association studies is to determine the
genetic basis for complex diseases. Speciﬁcally, the aim is to identify
genetic variants which either directly inﬂuence complex diseases or are in
linkage disequilibrium with such causal variants.
Biallelic SNPs are often used as genetic markers in association studies
thanks to availability of high-density SNP maps published by International
SNP Map Working Group (2001) and International HapMap Consortium
(2003).
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Deﬁnition
Single nucleotide polymorphism (SNP, pronounced as “snip”) is a single
nucleotide (A, T, C, or G) variation of the DNA sequence that occurs in at
least 1% of the population.
For example, DNA fragments AAGCCTA and AAGCTTA from two
subjects diﬀer in a single nucleotide. In this example, the bases C and T
are referred to as alleles, alternative forms of a DNA segment at a single
locus.
A SNP is often coded as 1 if a rare allele is present at a SNP site and 0,
otherwise.
Yulia Marchenko (StataCorp) Haplotype-based disease association analysis September 9, 2008 4 / 37Haplotypes and diplotypes
Deﬁnition
Haplotype is a sequence of closely linked SNPs on the same chromosome
within the genomic region of interest. Diplotype is a set of two haplotypes
humans carry in the pair of homologous chromosomes.
Using binary coding of SNPs, a haplotype can be represented as a binary
sequence and a diplotype can be represented as a pair of binary sequences.
Therefore, with M SNP sites (loci), there are 2M possible haplotypes and
22M possible diplotypes.
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In haplotype-based disease association studies, a subject’s genetic
information is described by a diplotype. In practice however we observe
genotypes instead of diplotypes.
Deﬁnition
Genotype is a combination of the haplotypes from a pair of homologous
chromosomes.
Mathematically speaking, if H1 and H2 are two haplotypes (binary
sequences), a genotype G = H1 + H2 is the sum of these two binary
sequences resulting in a sequence of the numbers 0, 1, and 2.
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Data from a case-control haplotype-based disease association study usually
consist of
a disease (or case-control) status D = 0,1;
genotype data from M tightly linked SNPs
G = (g1,...,gM),gk ∈ {0,1,2}; and
subjects’ characteristics and environmental exposures
X = (x1,...,xp).
We consider the case when the data are collected from samples of
unrelated individuals using the retrospective sampling scheme.
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select people with D = 1 and sample from them to obtain values of
covariates Z;
select people with D = 0 and sample from them to obtain values of
covariates Z;
samples (covariate values) are obtained conditional on the disease
status D.
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Recall that under the case-control sampling design, the likelihood function
fZ|D(z|d) =
Pr(D = d|Z = z)fZ(z)
Pr(D = d)
depends on the probability of disease Pr(D = d) = πd in the population,
the covariate distribution fZ() in the population, and the likelihood
function under the prospective design Pr(D|Z).
Under the considered logistic model,
Pr(D = 1|Z = z;α0,β) = K(α0 + β⊤z)
where K(a) = exp(a){1 + exp(a)}−1 and β = (β1,...,βp)⊤.
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functions
Prentice and Pyke (1979) showed that one can obtain MLEs of β by
ﬁtting the standard logistic model (ignoring the retrospective design) to
case-control data without any parametric assumptions about the covariate
distribution fZ().
Roeder et al. (1996), besides extending the result to the case of covariates
measured with error, provided the explicit relationship between the
parameters of the prospective and retrospective likelihood functions:
β⋆ = β and α⋆
0 = α0 + log(n1/n0) − log(π1/π0)
where n1 and n0 are the respective numbers of cases and controls.
Note
Intercept α0 is not estimable from a prospective logistic regression with
case-control data unless the probability of a disease in the population π1 is
known.
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with case-control data
Breslow et al. (2000) showed that the standard logistic regression is
semiparametric-eﬃcient (the variance of coeﬃcients attains the lower
bound of the underlying semiparametric model) under the case-control
sampling design.
Assumption
The semiparametric-eﬃciency of the prospective-type analysis of
case-control data holds under the assumption of an arbitrary covariate
distribution.
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With SNP genetic data, we want to study the eﬀect of risk haplotypes
(target haplotypes whose eﬀect on a disease is of interest) on the disease
and possibly their interaction with environmental exposures X.
Subjects’ genetic information consists of diplotypes, haplotype pairs,
Hd = (Hk,Hl) with constituent haplotypes Hk and Hl. As such, the eﬀect
of risk haplotypes may be modeled according to various genetic models
depending on the number of copies of the risk haplotype present in a
subject’s diplotype.
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Haplotype-eﬀects logistic model with risk haplotypes H⋆ and
environmental factors X is
Pr(D = 1|X,Hd;α0,βX,γH⋆) = K{α0 + βXX + m(Hd,X;γH⋆)}
where function m(Hd,X;γH⋆) is linear in risk haplotype parameters γH⋆
with coeﬃcients determined by a risk haplotype model (or mode of
inheritance).
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Consider a single risk haplotype H⋆
1 and its main eﬀect on the disease. In
general (under the codominant model),
m{Hd = (Hk,Hl);γH⋆
1 } = {I(Hk = H⋆














codominant – the eﬀects of having two copies of a risk haplotype in
a diplotype and a single copy can be diﬀerent
additive – having two copies of a risk haplotype in a diplotype
doubles the eﬀect compared to having only one copy; βr
H⋆
1 = 0
recessive – only having exactly two copies of a risk haplotype has an
eﬀect on a disease; βa
H⋆
1 = 0
dominant – having one or two copies of a risk haplotype has the
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We can add the interaction eﬀect of H⋆
1 with an environmental factor X1.
Then, under the codominant model,
m(Hd,X1;γH⋆
1 ) = {I(Hk = H⋆








+ {I(Hk = H⋆



































1 X1 = −βa
H⋆
1 X1 under the dominant model.
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A haplotype-eﬀects logistic regression model is
Pr(D = 1|X,Hd;α0,βX,γH⋆) = K(α0 + β⊤
XX + γ⊤
H⋆M)
where components of a column vector M (genetic covariates) depend on
subjects’ diplotypes, chosen risk haplotypes H⋆, the chosen mode of
inheritance, and are evaluated using expressions described earlier for
function m(Hd,X;γH⋆).
How do we estimate the parameters of the above model?
Let Z = (X,M) and β = (β⊤
X,γ⊤
H⋆)⊤ and follow Prentice and Pyke’s
approach as before.
So, are we done?
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We have additional information about the distribution of covariates –
can still utilize the prospective approach but the results are no longer
semiparametric-eﬃcient.
In practice, we usually observe genotypes instead of diplotypes –
“phase ambiguity” arises (will discuss later).
Genotype data are often missing – need to deal with the missing-data
problem to avoid a possibly signiﬁcant reduction in the sample size.
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gene-environment independence – f (X,Hd) = g(X)q(Hd;θ)
population in Hardy-Weinberg equilibrium (HWE) – assumption
about the distribution of genetic covariates:
q{Hd = (Hk,Hl);θ} = θ2
k if Hk = Hl
= 2θkθl if Hk  = Hl
where θk denotes the frequency for haplotype Hk.
population deviates from HWE according to a certain parametric
model. For example,
q{Hd = (Hk,Hl);θ} = θ2
k + ρθk(1 − θk) if Hk = Hl
= (1 − ρ)θkθl if Hk  = Hl
where ρ denotes the inbreeding coeﬃcient.
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Recall, that we observe subjects’ genotypes G = Hk + Hl instead of
diplotypes Hd = (Hk,Hl). This creates a problem of “phase ambiguity”
for heterozygous subjects who carry diﬀerent alleles at two or more loci.
Deﬁnition
Homozygous subjects carry two copies of the same allele at all SNP loci.
Heterozygous subjects carry diﬀerent alleles at at least one locus.
Example
2 SNPs – H1 = (0,0), H2 = (0,1), H3 = (1,0), and H4 = (1,1);
For a G = (1,1) there are 2 diplotypes {H1,H4} and {H2,H3}
consistent with it, i.e., G = H1 + H4 = H2 + H3;
for subjects with such genotype the phase is indeterminant.
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Genotype data G:
missing at random;
missing components of G may be any value from {0,1,2}.
Thus, for subjects with missing genotype data we take into account
multiple possible genotypes (and consequently multiple possible
diplotypes) when computing the likelihood.
Note
We can view the “phase ambiguity” problem as a missing-data problem.
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Taking into account the discussed characteristics, the retrospective
likelihood function of case-control SNP-based data is





G Pr(D = d|X = x,Hd = hd)q(hd;θ)
Pr(D = d)
where Hd
G = {(Hk,Hl): the haplotype pair is consistent with G} is the set
of all possible diplotypes consistent with the observed genotype data G.
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Idea of the method: proﬁle the possibly inﬁnite-dimensional (if X has
continuous components) nuisance distribution of X out of the
retrospective likelihood ﬁrst. Then maximize the resulting proﬁle
retrospective log-likelihood with respect to parameters of interest.
For details of the method and formulas, see Spinka et al. (2005), Lin et al.
(2005), and Lin and Zeng (2006).
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The retrospective sampling design is commonly used when conducting
studies of rare diseases. Under the assumption of a rare disease,
Pr(D = d |Hd,X;α0,βX,γH⋆) ≈ exp{d(α0 +β⊤
XX +γ⊤
H⋆M)}, d = 0,1
Lin and Zeng (2006) employed the rare-disease assumption for the
development of their algorithm. Spinka et al. (2005) provided a method
that does not make the assumption of a rare disease but noted that this
assumption results in a simpler and more stable algorithm.
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The Stata command haplologit estimates haplotype eﬀects and
haplotype-environment interactions from case-control genetic (SNP-based)
data in the very important special case of
a rare disease;
a single candidate gene in HWE;
independence of genetic and environmental factors.
haplologit accommodates three types of haplotype risk models: additive
(the default), dominant, or recessive. It implements the retrospective
proﬁle-likelihood methods of Spinka et al. (2005) and Lin and Zeng (2006)
which are equivalent under the assumptions of a rare disease and HWE.
For details about the syntax of haplologit, underlying algorithms, and
examples see Marchenko et al. (2008).
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Biological hypothesis
Calcium prevents colorectal cancer, possibly through the calcium-sensing
receptor.
Study goal.
To investigate the interactions of dietary calcium intake and genetic
variants in the calcium-sensing receptor (CaSR) region (Peters et al. 2004;
Lobach et al. 2007; Chen et al. 2008).
Data source.
Data come from Prostate, Lung, Colorectal, and Ovarian Cancer Screening
Trial at the National Cancer Institute, USA and contain information on
participants’ dietary food intake and genotype data from three
nonsynonymous SNPs in the CaSR region.
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SNP variables
Variables g casr 01, g casr 02, and g casr 03 record genotype data
from 3 nonsynonymous SNPs in exon 7 of the CaSR gene.
. describe g_casr_01 g_casr_02 g_casr_03 casecontrol Ldtcal sex agerand Caucasian
storage display value
variable name type format label variable label
g_casr_01 byte %8.0g first SNP locus
g_casr_02 byte %8.0g second SNP locus
g_casr_03 byte %8.0g third SNP locus
casecontrol byte %8.0g case-control status
Ldtcal float %9.0g log(1+dietary calcium from FFQ)
sex byte %8.0g gender: 1 = Male, 2 = Female
agerand float %9.0g age (in years)
Caucasian float %9.0g ethnicity: 0 = Non Caucasian, 1
= Caucasian
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Total of 1312 subjects after eliminating subjects with missing calcium
information – 644 cases and 668 controls.
. summarize g_casr_01 g_casr_02 g_casr_03 casecontrol Ldtcal sex agerand Caucasian
Variable Obs Mean Std. Dev. Min Max
g_casr_01 1312 .1623476 .3968026 0 2
g_casr_02 1312 .1021341 .3176886 0 2
g_casr_03 1312 .2804878 .4992599 0 2
casecontrol 1312 .4908537 .500107 0 1
Ldtcal 1312 6.767107 .506731 4.893262 8.544137
sex 1312 1.304878 .4605313 1 2
agerand 1312 62.53329 5.276247 55.042 74.99
Caucasian 1312 .9458841 .2263324 0 1
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Example
We want to investigate the interaction of dietary calcium intake (mg/day)
and the three common haplotypes coded as “001”, “010”, and “100”.
Other rare haplotypes are combined with the most common haplotype,
“000”, to form the base (comparison) haplotype category.
Syntax
. haplologit casecontrol sex Ldtcal agerand Caucasian,
> snpvars(g_casr_01 g_casr_02 g_casr_03) inher(d)
> riskhap1("001") riskhap2("010", inter(Ldtcal))
> riskhap3("100", inter(Ldtcal))
> nolog happrefix("_")
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Building consistent haplotype pairs:
Obtaining initial haplotype frequency estimates from the control sample:
Haplotype frequency EM estimation
Number of iterations = 53






* frequencies > .0015244
(Continued on next page)
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Performing gradient-based optimization:
Haplotype-effects logistic regression
Mode of inheritance: dominant Number of obs = 1312
Genetic distribution: Hardy-Weinberg equilib. Number phased = 1253
Genotype: g_casr_01 g_casr_02 Number unphased = 59
g_casr_03 Number missing = 0
Wald chi2(9) = 36.61
Retrosp. profile log likelihood = -2769.5997 Prob > chi2 = 0.0000
casecontrol Coef. Std. Err. z P>|z| [95% Conf. Interval]
sex -.1222521 .12261 -1.00 0.319 -.3625632 .118059
Ldtcal -.0553412 .1213515 -0.46 0.648 -.2931857 .1825032
agerand .0370709 .0105986 3.50 0.000 .016298 .0578439
Caucasian .1579015 .2517616 0.63 0.531 -.3355422 .6513452
_001 -.2915038 .1238556 -2.35 0.019 -.5342563 -.0487513
_010 -.4371039 .1932946 -2.26 0.024 -.8159544 -.0582533
_100 -.2507072 .1535909 -1.63 0.103 -.5517398 .0503254
_010*Ldtcal -.7947331 .2759949 -2.88 0.004 -1.335673 -.253793
_100*Ldtcal -.5047162 .2205877 -2.29 0.022 -.9370601 -.0723723
_cons .1193802 .2939819 0.41 0.685 -.4568137 .6955741
Note: _cons = b0 + ln(N1/N0) - ln{Pr(D=1)/Pr(D=0)}
(Continued on next page)
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Haplotype frequencies
Coef. Std. Err. z P>|z| [95% Conf. Interval]
_000 .7029555 .0121212 57.99 0.000 .6791983 .7267127
_001 .1527102 .0095211 16.04 0.000 .1340491 .1713713
_010 .0578413 .0063148 9.16 0.000 .0454646 .070218
_100 .086493 .0075409 11.47 0.000 .0717131 .1012729
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haplotype main eﬀects
signiﬁcant dominant eﬀects of “001” and “010” haplotypes
environmental factors
signiﬁcant ﬁndings – age is associated with an increased risk of the
disease;
nonsigniﬁcant ﬁndings – an increased risk of advanced colorectal
adenoma for Caucasians, males, and subjects with lower calcium
intake
haplotype-environment interactions
Both interaction terms, hap 010*Ldtcal and hap 100*Ldtcal, are
statistically signiﬁcant at the 1% and 5% levels, respectively. This
agrees with results obtained in Lobach et al. (2007).
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allow modeling of departures from HWE according to a number of
speciﬁc models as described in Lin and Zeng (2006)
weaken the gene-environment independence assumption (e.g. Cheng
et al. 2008)
complete the list of genetic models by adding a codominant model
allow multiple candidate genes and gene-gene interactions
allow population stratiﬁcation
handle large number of markers – important in genome-wide
association studies
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